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Abstract 
This study aimed to evaluate the prognostic
value of acute phase blood pressure in patients
with  acute  ischemic  stroke  by  determining
whether or not it contributes to clinical out-
come.  We  studied  515  consecutive  patients
admitted within the first 48 hours after the
onset of ischemic strokes, employing systolic
and  diastolic  blood  pressure  measurements
recorded  within  36  hours  after  admission.
High  blood  pressure  was  defined  when  the
mean of at least 2 blood pressure measure-
ments was ≥200 mmHg systolic and/or ≥110
mmHg diastolic at 6 to 24 hours after admis-
sion  or  ≥180  mmHg  systolic  and/or  ≥105
mmHg diastolic at 24 to 36 hours after admis-
sion. The high blood pressure group was found
to include 16% of the patients. Age, sex, dia-
betes  mellitus,  hypercholesterolemia,  atrial
fibrillation, ischemic heart disease, stroke his-
tory, carotid artery stenosis, leukoaraiosis, NIH
Stroke Scale (NIHSS) on admission and mor-
tality  were  not  significantly  correlated  with
either  the  high  blood  pressure  or  non-high
blood pressure group. High blood pressure on
admission was significantly associated with a
past history of hypertension, kidney disease,
the  modified  Rankin  Scale  (mRS)  on  dis-
charge  and  the  length  of  stay.  On  logistic
regression analysis, with no previous history
of hypertension, diabetes mellitus, atrial fibril-
lation, and kidney disease were independent
risk  factors  associated  with  the  presence  of
high  blood  pressure  [odds  ratio  (OR),  1.85
(95% confidence interval (CI): 1.06-3.22), 1.89
(95% CI: 1.11-3.22), and 3.31 (95% CI: 1.36-
8.04), respectively]. Multi-organ injury may be
presented in acute stroke patients with high
blood pressure. Patients with high blood pres-
sure had a poor functional outcome after acute
ischemic stroke.
Introduction
It is well-known that blood pressure is often
elevated in the early stage of acute ischemic
stroke.
1 This early elevation in blood pressure
is  considered  to  play  an  important  role  in
maintaining the cerebral circulation and col-
lateral  blood  circulation  in  the  penumbra
region; however, the mechanism is not fully
understood.
2-4 Some  reports  suggest  that  an
initially high blood pressure is associated with
a poor prognosis,
5-8 while other reports suggest
that it contributes to a more favorable progno-
sis
9 or does not affect the prognosis,
10 and eval-
uations have not been adequately conducted. 
In this study, we evaluated the clinical char-
acteristics of acute ischemic stroke cases with
very high blood pressure in acute phase.
Materials and Methods
We studied 515 consecutive patients (309
male and 206 female patients, mean age: 73
years old) admitted within the first 48 hours
after  the  onset  of  ischemic  stroke  between
April 2003 and December 2007 from our hospi-
tal. Those who showed a mean of at least 2
blood pressure recordings of ≥200 mmHg sys-
tolic and/or ≥110 mmHg diastolic at 6 to 24
hours after admission or ≥180 mmHg systolic
and/or ≥105 mmHg diastolic at 24 to 36 hours
after  admission  were  assigned  to  Group  1,
11
and the remaining patients were assigned to
Group  2  (≥90  mmHg  systolic  or  ≥48  mmHg
diastolic). We excluded patients who received
thrombolysis  or  intra-arterial  therapies.  We
compared the clinical entity of the stroke, the
site of the infarct, risk factors, carotid artery
stenosis, cerebral white matter lesions, severi-
ty, and mortality between the two groups. The
study protocol was acknowledged and author-
ized  by  the  Institutional  Review  Board  of
Okayama Medical Center in Japan.
Clinical entities were classified into lacu-
nar,  atherothrombotic  and  cardioembolic
infarctions  according  to  the  3rd  Edition  of
Cerebrovascular Disease Classification by the
National  Institute  of  Neurological  Disorders
and  Stroke  (NINDS-III).
12 The  site  of  the
infarct was classified into supratentorial small
vessels,  supratentorial  cortical  branches,  as
well as supratentorial and supra- and sub-ten-
torial lesions. Risk factors were defined as fol-
lows:  high  blood  pressure  –  those  who  had
been  diagnosed  with  hypertension,  and  had
already taken anti-hypotensive drugs; diabetes
mellitus  –  those  who  had  a  fasting  glucose
level above 126 mg/dL and HbA1c higher than
6.5%, or those who had been taking antihyper-
glycemic drugs; hypercholesterolemia – those
who exhibited a total cholesterol level higher
than  220  mg/dL  during  hospitalization,  or
those who had been taking antihyperlipidemic
drugs; degree of severity – according to the
NIH  stroke  scale  (NIHSS)  and  the  modified
Rankin Scale (mRS); carotid artery stenosis of
more than 70% as assessed by the NASCET
index  was  considered  significant;  cerebral
white matter lesions were divided into grade 0-
3 based on the study by Fazekas et al.
13 Grade 0,
no cerebral matter lesions; Grade 1, periven-
tricular hyperintensities (PVH) on the bilateral
anterior  or  posterior  horn  or  patchy  lesions;
Grade 2, enlarged, patchy lesion and early con-
fluent stage; Grade 3, enlarged PVH surround-
ing the lateral cerebral ventricle. Grade ≥2 on
cerebral white matter lesion scoring indicates
significant white matter disease. Although the
general  recommendation  in  Japan  is  not  to
treat elevated blood pressure during the first
day of ischemic stroke, antihypertensive (a cal-
cium antagonist) was administered only when
extreme hypertension of ≥220 mmHg systolic
and/or  ≥130  mmHg  diastolic  continued  or
patients had aortic dissection, acute myocar-
dial infarction, heart failure or kidney failure.
Statistical  analysis  was  conducted  using
SPSS16.0 (SPSS Inc.). We employed the χ
2 test
to compare the backgrounds of the patients,
and  non-parametric  Mann-Whitney  test  to
compare the clinical evaluation scales between
the  two  groups.  Logistic  regression  analysis
was conducted to evaluate the association of
the risk factors and presence of a high blood
pressure, and the odds ratio and 95% confi-
dence  interval  (CI)  were  evaluated.  p<0.05
was considered significant.
Results
A  total  of  83  patients  (16%)  belonged  to
Group 1. No significant differences in mean
age,  sex  and  clinical  entities  were  noted
between the groups. In both groups, the most
common site of the infarct was supratentorial
cortical branches.
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of patients with a history of hypertension was
75.9% and 57.6%, and that of kidney disease
was 12.0% and 3.5% in Groups 1 and 2, respec-
tively, with significant differences. There was
no significant difference regarding other risk
factors; however, the incidence of risk factors
was higher in Group 1. Concerning the degree
of severity, mRS on discharge and the length of
stay  were  significantly  higher  in  Group  1.
There was no significant difference in NIHSS
on admission and the mortality rate, but it was
higher in Group 1 (Table 1).To clarify the asso-
ciation of the risk factors and the presence of
a  high  blood  pressure,  logistic  regression
analysis was conducted. Regarding the factors
excluding a history of hypertension, a history
of diabetes mellitus, arterial fibrillation, and
kidney  disease  were  significantly  associated
with an odds ratio (OR) of 1.85 (95% confi-
dence  interval  (CI):  1.06-3.22,  p=0.02),  1.89
(95% CI: 1.11-3.22, p=0.02), and 3.31 (95% CI:
1.36-8.04, p=0.01), respectively, and they were
independent risk factors for having elevated
blood  pressure  during  the  acute  phase  of
stroke. Other factors did not show a significant
correlation (Table 2).
Discussion
In  this  study,  Group  1  indicated  the  very
high  blood  pressure  group;  the  size  of  this
group (n=83) was relatively small although the
entire  study  group  as  a  whole  was  large  at
n=515. The rates of patients with a history of
high blood pressure, and kidney disease were
significantly higher in Group 1, and they were
more  likely  to  have  a  history  of  being  pre-
scribed  several  kinds  of  antihypertensive
drugs. They were also more likely to show atri-
al fibrillation and diabetes mellitus, although
the difference was not significant. Their mRS
scores  on  discharge  and  the  length  of  stay
were  significantly  higher,  though  NIHSS  on
admission was not significant between the two
groups, which suggested that they were more
likely to have a poorer prognosis. On logistic
regression analysis with no previous history of
hypertension, diabetes mellitus, arterial fibril-
lation, and kidney disease were independent
risk factors associated with the presence of a
high blood pressure. In patients without a his-
tory of hypertension, patients with diabetes,
atrial  fibrillation,  and  kidney  disease  were
more  likely  to  have  elevated  blood  pressure
early during stroke. Atrial fibrillation and kid-
ney disease are common complications of late
hypertensive  disease  and  hypertension  is
more prevalent among patients with diabetes.
These results suggest that multi-organ injury
may  be  present  in  patients  with  high  blood
pressure,  and  thus  acute  phase  high  blood
pressure  is  related  to  a  poor  prognosis.
Generally, the blood pressure is elevated in the
early stage of stroke, and it reaches a plateau
within 24 hours, and then gradually starts to
decrease  in  a  week.  In  this  study,  only  28
(5.4%) and 10 (1.9%) acute inpatients sponta-
neously had a blood pressure of higher than
180/105 mmHg one week and two weeks after
admission, respectively. The acute phase ele-
vation in blood pressure is considered to play
an important role in maintaining cerebral and
collateral  blood  circulation  in  the  penumbra
region. However, the continuation of an elevat-
ed blood pressure has been suggested to lead
to brain edema and reinfarction of ischemic
lesions.
14-16 Large  epidemiological  studies  of
acute ischemic stroke patients have demon-
strated a U-shaped curve with respect to pre-
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Table 1. Baseline characteristics of subjects.
Characteristic Group 1 Group 2 p value
n=83 n=432
Mean age (years) [mean±SD] 75.0±11.1 73.1±11.9 N.S.
Male [%] 54.2 61.1 N.S.
Clinical entities [%]
Lacunar infarction 33.7 35.5 N.S.
Atherothrombotic infarction 26.5 26.3
Cardioembolic infarction 25.6 26.6
Unknown cause 14.2 11.6
The site of the infarct [%]
Supratentrial small vessels 36.1 41.2 N.S.
Supratentrial cortical branches 51.8 40.5
Subtentrial lesions 12.0 17.1
Supra- and sub-tentrial lesions 0 1.2
Hypertension [%] 75.9 57.6 0.001
Diabetes mellitus [%] 36.1 25.0 N.S.
Hypercholesterolemia [%] 26.5 25.0 N.S.
Atrial fibrillation [%] 39.8 25.7 N.S.
Ischemic heart disease [%] 18.3 14.2 N.S.
Stroke history [%] 33.7 29.4 N.S.
Kidney disease [%] 12.0 3.5 0.003
Carotid artery stenosis [%] 10.8 6.9 N.S.
Leukoaraiosis [%] 18.1 18.3 N.S.
NIHSS on admission [mean±SD] 8.7±7.0 7.5±7.8 N.S.
mRS on discharge [mean±SD] 3.1±1.8 2.4±1.8 0.005
The length of stay (days) [mean±SD] 28.2±21.4 22.7±17.5 0.007
Mortality [%] 6.0 3.5 N.S.
Group 1 represents subjects with high blood pressure. Group 2 represents  the remaining patients; mRS: modified Rankin Scale; 
NIHSS: NIH Stroke Scale; N.S.: not significant.
Table 2. Odds ratio for an association of risk factors with the presence of a high blood
pressure.
OR 95%CL p value
Age (>75) 1.12 0.65~1.92 0.69
Male 0.73 0.44~1.22 0.23
Diabetes mellitus 1.85 1.06~3.22 0.03*
Hypercholesterolemia 1.05 0.59~1.88 0.86
Atrial fibrillation 1.89 1.11~3.22 0.02*
Stroke history 1.11 0.66~1.89 0.69
Ischemic heart disease 1.23 0.64~2.36 0.53
Kidney disease 3.31 1.36~8.04 0.01*
Carotid artery stenosis 1.48 0.62~3.50 0.38
Leukoaraiosis 0.95 0.49~1.84 0.88
Mortality 1.40 0.46~4.20 0.55
*p<0.0.5senting  blood  pressure  and  outcomes.
7
A low blood pressure group of patients would
be  put  in  with  Group  2.  Our  study  demon-
strates that high blood pressure values were
highly associated with early recurrent stroke
and fatal brain edema. 
Regarding  the  management  of  hyperten-
sion,  the  2004  Japanese  guidelines  for  the
management  of  the  stroke
17 states  that  the
careful  administration  of  antihypertensive
drugs  is  recommended  only  when  extreme
hypertension  of  ≥220  mmHg  systolic  and/or
≥130  mmHg  diastolic  continues  or  patients
have  aortic  dissection,  acute  myocardial
infarction,  heart  failure  or  kidney  failure.
However, the grade of recommendation is C1,
which means that it is not based on adequate
scientific evidence.
Some studies have reported that, in patients
who were administered a high-dose bolus of
nimodipine, a calcium antagonist, in the acute
stage  of  stroke,  a  decrease  in  the  diastolic
pressure  and  deterioration  of  neurological
scores were observed, which suggests the risk
of rapid blood pressure reduction.
18 However,
the target blood pressure specifically related to
the clinical entity, history and coexisting ill-
nesses  has  not  yet  been  proposed.  The
ACCESS study which was published recently
reported that a 7-day course of candesartan, an
angiotensin receptor II blocker (ARB), started
within 36 hours rather than seven days after
an acute ischemic stroke reduced the occur-
rence of cardiovascular events within a year
after the stroke by 47.5%.
11These findings indi-
cate the need to re-examine the conventional
management  of  hypertension  in  the  early
stage  of  acute  brain  stroke.  In  the  present
study, it was suggested that patients with high
blood pressure were more likely to have a his-
tory  of  hypertension,  kidney  disease  and
carotid stenosis. In these patients, a gradual
decrease in the blood pressure on careful fol-
low-up of the clinical symptoms may be favor-
able.
There  are  some  limitations  to  this  study.
First,  the  number  of  patients  was  relatively
small.  Therefore,  further  evaluation  with  a
larger number of patients is required. Second,
the prognosis was measured by mRS scores on
discharge; thus a follow-up period of three or
six months is necessary. A large randomized
comparison trial to investigate indications of
antihypertensive  drugs  in  the  early  stage  of
acute stroke is awaited. 
Conclusions
In this study, the rates of patients with a his-
tory of high blood pressure, kidney disease, the
mRS scores on discharge and the length of stay
were  significantly  higher  in  Group  1.  Multi-
organ injury may be present in these patients,
and acute phase high blood pressure can be
one of the factors indicating a poor prognosis.
It was suggested that antihypertensive treat-
ments specifically related to the history and
coexisting illnesses are required.
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